News & Events

Last patient visit completed

The last patient follow-up visit has now taken place meaning that all participants randomised into the study have now completed their final visits. Huge thanks to all participants for their commitment and enthusiasm for the study.

Last modified: Mon, 27 Oct 2025 09:38:40 GMT

End of Screening

We are no longer looking for any more participants for the AuToDeCRA-2 study after the last participant was successfully randomised into the study. A big thank you to everyone who expressed an interest in taking part in the study

Last modified: Mon, 27 Oct 2025 09:35:55 GMT

AuToDeCRA-2 on the BBC

Professor Isaacs and his team welcomed the BBC to Newcastle Hospital's Clinical Research Facility to talk about the work being done in the AuToDeCRA-2 study.

Last modified: Wed, 26 Mar 2025 17:04:19 GMT

Study recruitment total

Recruitment into the AuToDeCRA-2 study continues at a good pace. We have currently randomised 20 participants into the study.

Last modified: Wed, 26 Mar 2025 16:53:27 GMT

AuToDeCRA-2 study open to recruitment

The Newcastle team received the ok to start recruitment into the AuToDeCRA-2 study.

Last modified: Mon, 04 Mar 2024 15:49:29 GMT

Regulatory Approvals

AuToDeCRA-2 receives MHRA, REC and HRA Approvals

Last modified: Wed, 15 Nov 2023 14:31:42 GMT

Successful delivery of TolDC

Our first trial participant has successfully received our TolDC product.

Last modified: Wed, 24 Apr 2024 15:11:59 BST

Final study visits

The first participants in the AuToDeCRA-2 are now beginning to complete their final study visits which is great. A big thank you to them all for giving up their time to support research into Rheumatoid Arthritis.

Last modified: Thu, 20 Jun 2024 10:57:31 BST